Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Efficacy of Methotrexate Versus Apremilast in the Treatment of Pruritus in Psoriasis: A Randomized Controlled Trial

NCT07432386 is registered in ClinicalTrials.gov with Zarmeen Khawar as lead sponsor.

NCT NCT07432386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07432386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Efficacy of Methotrexate Versus Apremilast in the Treatment of Pruritus in Psoriasis: A Randomized Controlled Trial
Lead sponsor
Zarmeen Khawar
Phase
Phase 4
Overall status
Not yet recruiting
Start date
May 14, 2026
Completion date
October 14, 2026
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pruritus, psoriasis